Sales forecast of select Novartis R&D projects worldwide 2028
In 2028, Novartis's R&D project Piqray is expected to generate 670 million U.S. dollars in sales worldwide, while the Iptacopan is projected to generate around 609 million U.S. dollars globally in the same year. This statistic illustrates the sales forecast of select Novartis R&D projects worldwide in 2028.